FIRST-ENGOT-Ov44 (ENGOT/GCIG/Tesaro)
Trial Description:
A Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Closed to Recruitment
Contact person:
epujade